Elevated plasma HSP90α as a prognostic marker in EGFR-mutant non-small cell lung cancer.

Oncol Lett · 2025 · PMC12319274 · PMID 40762018

Europe PMC DOI

hedged sentence

0.0270

closest p · 0.5× alpha

0.0270

boldest claim

The sentences

a decreasing trendP=0.027actually significant

Additionally, HSP90α expression revealed a decreasing trend in patients with the EGFR L858R mutation compared with those with wild-type EGFR (P=0.027).

also in 29,529 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.